Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis

Conditions:   Desmoid Tumors;   Aggressive FibromatosisIntervention:   Drug: PF-03084014Sponsors:   National Cancer Institute (NCI);   National Institutes of Health Clinical Center (CC)Active, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials